Paolo Ferrari

18.2k total citations
342 papers, 9.8k citations indexed

About

Paolo Ferrari is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Paolo Ferrari has authored 342 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Molecular Biology, 96 papers in Endocrinology, Diabetes and Metabolism and 78 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Paolo Ferrari's work include Hormonal Regulation and Hypertension (77 papers), Ion Transport and Channel Regulation (53 papers) and Birth, Development, and Health (33 papers). Paolo Ferrari is often cited by papers focused on Hormonal Regulation and Hypertension (77 papers), Ion Transport and Channel Regulation (53 papers) and Birth, Development, and Health (33 papers). Paolo Ferrari collaborates with scholars based in Italy, Switzerland and Australia. Paolo Ferrari's co-authors include Giuseppe Bianchi, P Weidmann, Felix J. Frey, Mara Ferrandi, Zygmunt S. Krozowski, Lucia Torielli, Grazia Tripodi, Brigitte M. Frey, Bernhard Dick and Paolo Barassi and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Paolo Ferrari

333 papers receiving 9.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paolo Ferrari Italy	52	3.1k	3.1k	2.4k	1.7k	1.2k	342	9.8k
Julie R. Ingelfinger United States	57	2.2k 0.7×	3.4k 1.1×	3.2k 1.3×	1.1k 0.7×	1.1k 0.9×	253	10.6k
Adam Whaley‐Connell United States	53	3.6k 1.2×	2.2k 0.7×	3.4k 1.4×	1.7k 1.0×	785 0.7×	217	10.4k
Dimitri P. Mikhailidis United Kingdom	60	4.6k 1.5×	2.0k 0.7×	3.7k 1.5×	3.2k 2.0×	1.2k 1.0×	372	14.3k
Berthold Hocher Germany	53	1.6k 0.5×	2.2k 0.7×	2.0k 0.8×	1.1k 0.7×	1.2k 1.0×	355	9.4k
Christian Delles United Kingdom	49	1.4k 0.4×	2.0k 0.6×	3.1k 1.3×	1.1k 0.7×	706 0.6×	283	8.5k
Atsunori Kashiwagi Japan	55	3.5k 1.1×	4.2k 1.4×	1.4k 0.6×	2.2k 1.3×	696 0.6×	231	11.3k
Francesco Perticone Italy	52	2.9k 0.9×	2.0k 0.7×	4.5k 1.9×	1.3k 0.8×	794 0.7×	269	10.4k
K. Borch‐Johnsen Denmark	59	5.5k 1.7×	1.8k 0.6×	3.0k 1.2×	1.7k 1.1×	601 0.5×	176	12.5k
James D. Best Australia	56	5.2k 1.7×	3.0k 1.0×	2.4k 1.0×	3.7k 2.3×	577 0.5×	241	13.2k
Alicia J. Jenkins Australia	61	5.0k 1.6×	2.8k 0.9×	1.9k 0.8×	2.3k 1.4×	436 0.4×	420	14.4k

Countries citing papers authored by Paolo Ferrari

Since Specialization

Citations

This map shows the geographic impact of Paolo Ferrari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Ferrari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Ferrari more than expected).

Fields of papers citing papers by Paolo Ferrari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Ferrari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Ferrari. The network helps show where Paolo Ferrari may publish in the future.

Co-authorship network of co-authors of Paolo Ferrari

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Ferrari. A scholar is included among the top collaborators of Paolo Ferrari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Ferrari. Paolo Ferrari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hsu, Shih-Che, Mara Ferrandi, Paolo Barassi, et al.. (2024). Selective SERCA2a activator as a candidate for chronic heart failure therapy. Journal of Translational Medicine. 22(1). 5 indexed citations

Low, Jun Siong, Federico Mele, Mathilde Foglierini, et al.. (2021). Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2. Science. 372(6548). 1336–1341. 85 indexed citations

Cippà, Pietro E., Federica Cugnata, Paolo Ferrari, et al.. (2020). A data-driven approach to identify risk profiles and protective drugs in COVID-19. Proceedings of the National Academy of Sciences. 118(1). 20 indexed citations

Gummer, Joel P. A., Robert D. Trengove, Elaine M. Pascoe, et al.. (2016). Association between serum hepcidin‐25 and primary resistance to erythropoiesis‐stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial. Nephrology. 22(7). 548–554. 14 indexed citations

Johnson, David W., Sunil V. Badve, Kim Dalziel, et al.. (2014). A Randomized, Placebo-Controlled Trial of Pentoxifylline On Erythropoiesis Stimulating Agent Resistance in Anaemic Patients with Chronic Kidney Disease - the Hero Trial. Queensland's institutional digital repository (The University of Queensland). 2 indexed citations

Irish, Ashley, et al.. (2013). Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death. Transplant Immunology. 28(4). 148–153. 53 indexed citations

Ferrari, Paolo, et al.. (2013). CONTRIBUTO ALLA CONOSCENZA DEI MYXOMICETI NIVICOLI DELLA PROVINCIA DI BRESCIA. 57–69. 1 indexed citations

Wong, Germaine, Kirsten Howard, Frans H.J. Claas, et al.. (2013). Modeling the Benefits and Costs of Integrating an Acceptable HLA Mismatch Allocation Model for Highly Sensitized Patients. Transplantation. 97(7). 769–774. 17 indexed citations

Wu, Chiung‐Jen, Christopher Chen, Wen‐Ter Lai, et al.. (2011). Assessment of reasons for not intensifying antihypertensive treatment in the Taiwanese population. Journal of the Formosan Medical Association. 110(12). 768–774. 1 indexed citations

10.

Ferrari, Paolo, et al.. (2009). Estimation of glomerular filtration rate: does haemoglobin discriminate between ageing and true CKD?. Nephrology Dialysis Transplantation. 24(6). 1828–1833. 13 indexed citations

11.

Micheletti, R., Fiorentina Palazzo, Paolo Barassi, et al.. (2006). Istaroxime, a Stimulator of Sarcoplasmic Reticulum Calcium Adenosine Triphosphatase Isoform 2a Activity, as a Novel Therapeutic Approach to Heart Failure. The American Journal of Cardiology. 99(2). S24–S32. 49 indexed citations

12.

Morineau, Gilles, et al.. (2006). Apparent Mineralocorticoid Excess. Journal of the American Society of Nephrology. 17(11). 3176–3184. 58 indexed citations

13.

Ferrandi, Mara, Isabella Molinari, Giuseppe Bianchi, & Paolo Ferrari. (2006). Ouabain-dependent signaling in caveolae as a novel therapeutic target for hypertension.. PubMed. 52(8). 15–8. 13 indexed citations

14.

Gabutti, Luca, Matthias Macháček, Claudio Marone, & Paolo Ferrari. (2005). Predicting intradialytic hypotension from experience, statistical models and artificial neural networks. Journal of Nephrology. 18(4). 409–416. 8 indexed citations

15.

Ferrari, Paolo, et al.. (2004). Low prevalence of nonconservative mutations of serum and glucocorticoid-regulated kinase (SGK1) gene in hypertensive and renal patients. Nephrology Dialysis Transplantation. 19(10). 2499–2504. 13 indexed citations

16.

Sgambato, Alessandro, Mario Migaldi, Beatrice Faraglia, et al.. (2001). Cyclin D1 expression in papillary superficial bladder cancer: Its association with other cell cycle‐associated proteins, cell proliferation and clinical outcome. International Journal of Cancer. 97(5). 671–678. 85 indexed citations

17.

Vannini, Simone, Anita C. Truttmann, Bendicht Wermuth, et al.. (1999). Permanently reduced plasma ionized magnesium among renal transplant recipients on cyclosporine. Transplant International. 12(4). 244–249. 27 indexed citations

18.

Smith, Roy E., et al.. (1996). Rat 11β-hydroxysteroid dehydrogenase type 2 enzyme is expressed at low levels in the placenta and is modulated by adrenal steroids in the kidney. Molecular and Cellular Endocrinology. 120(1). 67–75. 42 indexed citations

19.

Ferrari, Paolo, et al.. (1991). Reproducibility of insulin sensitivity measured by the minimal model method. Diabetologia. 34(7). 527–530. 54 indexed citations

20.

Weidmann, P, Paolo Ferrari, Yves Allemann, Claudia Ferrier, & S. Shaw. (1991). Developing essential hypertension: a syndrome involving ANF deficiency?. Canadian Journal of Physiology and Pharmacology. 69(10). 1582–1591. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact